Ken Griffin Selecta Biosciences Inc Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 16,800 shares of SELB stock, worth $14,112. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,800

Previous 200 8300.0%

Holding current value

$14,112

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.62 - $0.85 $265,085 - $363,423	-427,557 Reduced 81.12%	99,532 $83,000
Q4 2023 Feb 14, 2024	SELL	$0.67 - $1.35 $31,861 - $64,197	-47,554 Reduced 8.28%	527,089 $363,000
Q3 2023 Nov 14, 2023	BUY	$1.02 - $1.23 $19,707 - $23,764	19,321 Added 3.48%	574,643 $609,000
Q2 2023 Aug 14, 2023	BUY	$1.04 - $1.4 $49,543 - $66,693	47,638 Added 9.38%	555,322 $621,000
Q1 2023 May 15, 2023	BUY	$1.15 - $1.89 $373,962 - $614,599	325,185 Added 178.18%	507,684 $705,000

Q4 2022 Feb 14, 2023	SELL	$0.96 - $1.6 $638,884 - $1.06 Million	-665,505 Reduced 78.48%	182,499 $206,000
Q3 2022 Nov 14, 2022	BUY	$1.33 - $2.6 $765,932 - $1.5 Million	575,889 Added 211.63%	848,004 $1.39 Million
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.4 $22,926 - $47,906	-34,219 Reduced 11.17%	272,115 $357,000
Q1 2022 May 16, 2022	BUY	$1.23 - $3.31 $87,882 - $236,496	71,449 Added 30.42%	306,334 $377,000
Q4 2021 Feb 14, 2022	BUY	$2.89 - $4.43 $378,685 - $580,476	131,033 Added 126.17%	234,885 $765,000
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.62 $55,245 - $75,962	-16,442 Reduced 13.67%	103,852 $432,000
Q2 2021 Aug 16, 2021	SELL	$2.82 - $5.01 $239,590 - $425,654	-84,961 Reduced 41.39%	120,294 $502,000
Q1 2021 May 17, 2021	BUY	$2.92 - $5.07 $262,446 - $455,686	89,879 Added 77.9%	205,255 $929,000
Q4 2020 Feb 16, 2021	BUY	$1.64 - $3.42 $161,226 - $336,216	98,309 Added 576.02%	115,376 $350,000
Q3 2020 Nov 16, 2020	BUY	$2.18 - $2.84 $37,206 - $48,470	17,067 New	17,067 $42,000
Q2 2020 Aug 14, 2020	SELL	$1.83 - $4.06 $3.1 Million - $6.88 Million	-1,695,330 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.5 - $4.52 $2.51 Million - $7.56 Million	1,673,163 Added 7547.99%	1,695,330 $4.09 Million
Q4 2018 Feb 14, 2019	BUY	$2.66 - $15.93 $58,964 - $353,120	22,167 New	22,167 $58,000

Others Institutions Holding SELB

# of Institutions

Shares Held

41.4M

Call Options Held

16.8K

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account